Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy
This pilot study will evaluate the feasibility, acceptability, and perceived usefulness of the SWITCH mobile nutrition behavioral intervention among adults receiving GLP-1 receptor agonist therapy for obesity and/or type 2 diabetes. Participants will complete baseline assessments, receive a 6-week app-based nutrition intervention consisting of daily dietary self-monitoring and weekly learning modules, and complete follow-up assessments and a structured interview.
• • Age between 18 and 65 years.
‣ BMI between 30 - 49.9 kg/m2 and/or diagnosed with type 2 diabetes.
⁃ Currently prescribed and using GLP-1 receptor therapy for at least 4 weeks.
⁃ Own a smartphone (Android or iOS) with an active data plan to support app-based intervention delivery.
⁃ Residing anywhere in the United States.
⁃ Must be willing and able to reduce caloric intake.
⁃ Be free of major health or psychiatric diseases, drug, or alcohol dependency.
⁃ Willing to sign informed consent.